Femapent 2.5 mg 14 tabs

Available at Pharmaegy Pharmacy. Use as directed by your doctor.

Femapent 2.5 mg 14 tablets Composition: • Letrozole 2.5 mg per tablet. Femapent — an antitumor drug for hormone therapy Femapent is used for the treatment of hormone-dependent breast cancer in postmenopausal women. It belongs to aromatase inhibitors — drugs that reduce estrogen levels in the body. Pharmacological properties: Letrozole is a non-steroidal aromatase inhibitor. It blocks the conversion of androgens to estrogens, leading to a decrease in estrogen levels in the blood. This helps slow down or stop the growth of estrogen-dependent tumors. Indications for use: • Treatment of early breast cancer in postmenopausal women, especially in cases where estrogen is involved in tumor growth. • Prevention of breast cancer recurrence after completion of primary treatment (surgery, radiation therapy, chemotherapy). • Treatment of advanced breast cancer in postmenopausal women. • Preoperative treatment to reduce tumor size before surgery in some cases where chemotherapy is not suitable. • Ovulation stimulation in women with polycystic ovary syndrome (PCOS) as part of an infertility treatment protocol. • Prevention of breast cancer in postmenopausal women at high risk. • Sometimes used in cases of breast cancer in men under special medical supervision. Dosage and administration: • Usually: 2.5 mg (1 tablet) once daily, regardless of food intake. • Duration of therapy is determined individually and may last several years. Consultation with an oncologist is required before use.